What Are Trivastal L.A. 50 mg Tablets?
Trivastal L.A. 50 mg Tablets contain piribedil, a non-ergot dopamine receptor agonist primarily used to manage symptoms of Parkinson’s disease.
Parkinson’s disease is a progressive neurological disorder that affects movement and motor coordination.
It is associated with the degeneration of dopamine-producing nerve cells in a region of the brain called the substantia nigra.
Dopamine is a neurotransmitter involved in controlling movement, coordination, motivation, and several other neurological functions.
When dopamine activity decreases, patients may develop symptoms such as:
- Tremors
- Muscle rigidity
- Slowness of movement
- Difficulty initiating movement
- Reduced mobility
- Impaired coordination
- Changes in walking patterns
- Difficulty performing daily activities
Piribedil works by stimulating certain dopamine receptors in the brain.
It acts primarily on dopamine D2 and D3 receptors, helping compensate for reduced dopaminergic activity.
Trivastal L.A. uses a prolonged-release formulation designed to release piribedil gradually.
This allows the medicine to provide sustained dopaminergic activity over time.
Piribedil may be prescribed alone in selected patients with Parkinson’s disease or in combination with levodopa when clinically appropriate.
Important: Trivastal L.A. helps manage Parkinson’s disease symptoms but does not cure Parkinson’s disease or stop its underlying neurodegenerative progression.
How Do Trivastal L.A. 50 mg Tablets Work?
1. Stimulate Dopamine Receptors
Piribedil acts as a dopamine receptor agonist.
It stimulates dopamine receptors in the brain, particularly D2 and D3 receptors.
2. Compensate for Reduced Dopamine Activity
Parkinson’s disease involves reduced dopamine signaling in brain circuits responsible for movement.
Piribedil helps activate these pathways.
3. Improve Motor Function
Dopamine receptor stimulation may improve certain motor symptoms associated with Parkinson’s disease.
4. Reduce Bradykinesia
Bradykinesia refers to slowness of movement.
Piribedil may help improve movement initiation and speed in selected patients.
5. Help Reduce Muscle Rigidity
Dopaminergic stimulation may reduce muscle stiffness associated with Parkinson’s disease.
6. Support Tremor Control
Piribedil may improve tremor symptoms in some patients, although the response varies.
7. Provide Prolonged Drug Release
The long-acting formulation releases piribedil gradually, helping maintain drug exposure over the dosing interval.
The formulation must be swallowed whole to preserve its intended release characteristics.
Uses of Trivastal L.A. 50 mg Tablets
1. Parkinson’s Disease
Trivastal L.A. is primarily used to treat motor symptoms associated with Parkinson’s disease.
2. Bradykinesia
Piribedil may help reduce slowness of movement by stimulating dopamine receptors.
3. Muscle Rigidity
It may improve muscle stiffness and rigidity associated with Parkinson’s disease.
4. Parkinsonian Tremors
Piribedil may help control tremors in selected patients.
5. Early Parkinson’s Disease
Piribedil may be prescribed as monotherapy in selected patients with early Parkinson’s disease.
Treatment selection depends on age, symptom severity, and individual clinical factors.
6. Combination Therapy With Levodopa
Piribedil may be used alongside levodopa in certain patients requiring additional symptom control.
7. Movement Difficulties
By improving dopaminergic signaling, piribedil may help patients with selected movement difficulties caused by Parkinson’s disease.
8. Other Country-Specific Indications
Piribedil has been marketed for certain additional conditions in some countries.
These may include selected neurological or vascular-related symptoms.
However, such indications are not universally approved and should not be advertised without confirmation from the applicable product labeling.
Important: Trivastal L.A. is not a general treatment for memory loss, dizziness, hearing loss, or poor circulation unless a specific indication is supported by the locally approved prescribing information.
How to Take Trivastal L.A. 50 mg Tablets
Trivastal L.A. should be taken exactly as prescribed by a neurologist or other qualified healthcare professional.
Step-by-Step Administration Instructions
- Confirm the prescribed tablet strength.
- Check the prescribed daily dose and schedule.
- Swallow the tablet whole with water.
- Take the medicine with or after food if recommended to reduce nausea.
- Do not crush or chew the prolonged-release tablet.
- Follow the same dosing schedule each day.
- Avoid changing the dose independently.
- Do not stop treatment suddenly.
- Report unusual sleepiness or behavioral changes.
- Attend regular neurological follow-up appointments.
Dosage Information
The appropriate dose depends on:
- Parkinson’s disease severity
- Patient age
- Treatment response
- Concurrent levodopa treatment
- Blood pressure
- Kidney and liver function
- Adverse effects
- Other medical conditions
For Parkinson’s disease, piribedil treatment is commonly started at a lower total daily dose and adjusted gradually according to response and tolerability.
Depending on the approved regimen, treatment may involve multiple 50 mg tablets per day.
Important: A 50 mg tablet is the strength of one tablet, not necessarily the complete daily dose. The prescribed regimen must be followed.
Why Should Trivastal L.A. Be Swallowed Whole?
Trivastal L.A. is a prolonged-release formulation.
Crushing or chewing the tablet may interfere with its intended release characteristics.
Can Trivastal L.A. Be Stopped Suddenly?
Dopamine agonists should not be discontinued abruptly without medical supervision.
Sudden withdrawal may cause worsening Parkinsonian symptoms or a dopamine agonist withdrawal syndrome.
Possible withdrawal symptoms include:
- Anxiety
- Depression
- Fatigue
- Pain
- Sweating
- Apathy
- Sleep disturbances
Severe withdrawal or rapid changes in dopaminergic treatment may also be associated with serious complications.
Dose reduction should be supervised by the prescribing clinician.
Missed Dose
If a dose is missed, follow the product leaflet or prescribing neurologist’s instructions.
Do not take a double dose to compensate for a missed dose.
How Long Does Trivastal L.A. 50 mg Take to Work?
Piribedil begins exerting dopaminergic effects after absorption.
However, meaningful improvement in Parkinson’s symptoms may require gradual dose adjustment over several days or weeks.
The response depends on:
- Disease severity
- Prescribed dose
- Treatment duration
- Other Parkinson’s medicines
- Individual response
- Tolerability
Patients should not increase the dose independently if symptoms do not improve immediately.
Common Side Effects
Possible side effects include:
- Nausea
- Vomiting
- Dizziness
- Sleepiness
- Fatigue
- Low blood pressure
- Orthostatic hypotension
- Headache
- Abdominal discomfort
- Confusion
- Hallucinations
- Sleep disturbances
Some adverse effects may improve after dose adjustment.
However, persistent or worsening symptoms require medical assessment.
Serious Side Effects
Seek medical attention if you experience:
- Sudden episodes of falling asleep
- Severe dizziness or fainting
- Hallucinations
- Severe confusion
- Significant behavioral changes
- Uncontrolled compulsive behavior
- Severe allergic reactions
- Severe worsening of Parkinson’s symptoms
- Serious symptoms after abrupt withdrawal
Important Serious Adverse Reactions
Sudden Sleep Episodes: Dopamine agonists may cause sudden sleep onset, sometimes without adequate warning.
Orthostatic Hypotension: Blood pressure may fall when standing, increasing the risk of dizziness and falls.
Hallucinations: Some patients may experience visual or other hallucinations.
Impulse Control Disorders: Dopamine agonists may cause compulsive gambling, shopping, eating, or increased sexual urges.
Psychiatric Effects: Confusion, behavioral changes, and other psychiatric symptoms may occur.
Dopamine Agonist Withdrawal Syndrome: Abrupt discontinuation or rapid dose reduction may cause significant withdrawal symptoms.
Dyskinesia: In patients receiving levodopa, additional dopaminergic stimulation may contribute to involuntary movements.
Contraindications & Precautions
1. Allergy to Piribedil
Patients with known hypersensitivity to piribedil or other tablet ingredients should not take the medicine.
2. Cardiovascular Conditions
Patients with significant cardiovascular disease require careful medical assessment.
3. Recent Myocardial Infarction
Piribedil may be contraindicated in certain patients with acute cardiovascular conditions, depending on the product labeling.
4. Low Blood Pressure
Piribedil may cause orthostatic hypotension.
Patients should rise slowly from sitting or lying positions.
5. Sudden Sleep Episodes
Patients may experience excessive sleepiness or sudden sleep onset.
6. Driving and Machinery
Do not drive or operate machinery if experiencing drowsiness, dizziness, or sudden sleep episodes.
7. Hallucinations
Piribedil may cause hallucinations, particularly in susceptible patients.
8. Psychiatric Disorders
Patients with a history of psychosis or significant psychiatric illness require careful assessment.
9. Impulse Control Disorders
Patients and caregivers should watch for unusual compulsive behaviors.
10. Older Adults
Older patients may be more susceptible to confusion, hallucinations, dizziness, and falls.
11. Kidney Impairment
Patients with kidney disease should inform their prescriber.
Dose selection and monitoring depend on the clinical situation and product labeling.
12. Liver Impairment
Patients with significant liver disease should undergo appropriate medical assessment.
13. Pregnancy
Piribedil is generally not recommended during pregnancy because adequate human safety data are limited.
14. Breastfeeding
Piribedil is generally not recommended during breastfeeding.
Dopaminergic medicines may also suppress prolactin secretion and interfere with lactation.
15. Children
Piribedil is not routinely recommended for pediatric use.
16. Medication Interactions
Potentially relevant medicines include:
- Dopamine receptor antagonists
- Certain antipsychotic medicines
- Metoclopramide
- Other Parkinson’s medicines
- Levodopa
- Blood pressure-lowering medicines
- Sedating medicines
- Alcohol
Dopamine receptor antagonists may oppose the therapeutic effects of piribedil.
Concurrent use with levodopa may increase certain dopaminergic adverse effects.
17. Abrupt Withdrawal
Piribedil should not be stopped suddenly without medical supervision.
18. Medical Monitoring
Healthcare professionals may monitor:
- Parkinson’s symptom control
- Movement and mobility
- Blood pressure
- Orthostatic symptoms
- Daytime sleepiness
- Sudden sleep episodes
- Hallucinations
- Behavioral changes
- Impulse control disorders
- Dyskinesia
- Treatment adherence
- Medication interactions
- Response to dose adjustments
Advantages
- Contains piribedil 50 mg.
- Belongs to the non-ergot dopamine agonist class.
- Helps manage Parkinson’s disease symptoms.
- Stimulates dopamine D2 and D3 receptors.
- May improve bradykinesia.
- May reduce muscle rigidity.
- May help control tremors in selected patients.
- Available in prolonged-release formulation.
- May be prescribed as monotherapy in selected patients.
- May be combined with levodopa when appropriate.
- Supports individualized Parkinson’s disease treatment.
- Has an established role in dopaminergic symptom management.
Disadvantages / Limitations
- Requires a prescription.
- May cause nausea.
- May cause vomiting.
- May cause dizziness.
- May cause orthostatic hypotension.
- May cause excessive daytime sleepiness.
- May cause sudden sleep episodes.
- May cause hallucinations.
- May cause confusion.
- May cause impulse control disorders.
- May increase dyskinesia when combined with levodopa.
- Requires gradual dose adjustment.
- Should not be stopped abruptly.
- May interact with dopamine receptor antagonists.
- Requires regular neurological monitoring.
- Does not cure Parkinson’s disease.
- Does not stop neurodegenerative progression.
- Not suitable for every patient.
Important Notes
Brand Name: Trivastal L.A.
Generic Name: Piribedil.
Active Ingredient: Piribedil 50 mg.
Strength: 50 mg per tablet.
Dosage Form: Prolonged-Release Tablet.
Release Type: Long-Acting.
Drug Class: Non-Ergot Dopamine Receptor Agonist.
Therapeutic Category: Anti-Parkinsonian Medicine.
Primary Use: Parkinson’s disease symptom management.
Mechanism of Action: Dopamine D2 and D3 receptor stimulation.
Administration Route: Oral.
Dosage: Individualized according to neurological assessment.
Tablet Precaution: Swallow whole; do not crush or chew.
Sleep Precaution: May cause sudden sleep episodes.
Blood Pressure Precaution: May cause orthostatic hypotension.
Psychiatric Precaution: May cause hallucinations and behavioral changes.
Impulse Control Warning: Monitor for compulsive behaviors.
Withdrawal Warning: Do not stop treatment abruptly.
Pregnancy Precaution: Generally not recommended.
Storage: Follow manufacturer instructions.
Frequently Asked Questions
1. What is Trivastal L.A. 50 mg used for?
Trivastal L.A. 50 mg contains piribedil, a dopamine agonist primarily used to manage symptoms of Parkinson’s disease.
2. What is the active ingredient in Trivastal L.A. 50 mg?
The active ingredient is piribedil 50 mg.
3. What does L.A. mean in Trivastal L.A.?
L.A. means long-acting, referring to the prolonged-release formulation.
4. Is Trivastal L.A. a Parkinson’s medicine?
Yes. Piribedil is an anti-Parkinsonian dopamine receptor agonist.
5. How does Trivastal L.A. work?
It stimulates dopamine receptors, particularly D2 and D3 receptors, helping compensate for reduced dopamine signaling in Parkinson’s disease.
6. Can Trivastal L.A. improve movement?
Yes. It may improve certain movement symptoms, including bradykinesia and rigidity.
7. Can Trivastal L.A. reduce tremors?
Piribedil may help reduce tremors in selected patients, although individual responses vary.
8. Can Trivastal L.A. be taken with levodopa?
Yes. It may be prescribed with levodopa under neurological supervision.
9. How should Trivastal L.A. 50 mg be taken?
Swallow the prolonged-release tablet whole with water according to the prescribed schedule.
10. Can Trivastal L.A. tablets be crushed?
No. Crushing or chewing prolonged-release tablets may interfere with their intended release characteristics.

































































